GREENLAND MINES LTD Dividends, Cash
GREENLAND MINES LTD (GRML) reported Dividends, Cash of $146.33 thousand for the 9-month period ending 2023-09-30, per its 10-Q filed 2023-11-17.
Discontinued › Shareholders' Equity
us-gaap:DividendsCash · last filed 2023-11-17
- GREENLAND MINES LTD dividends, cash for the quarter ending 2023-09-30 was $22.61K.
- GREENLAND MINES LTD dividends, cash for the quarter ending 2023-06-30 was $5.74K.
- GREENLAND MINES LTD dividends, cash for the quarter ending 2023-03-31 was $117.98K.
- GREENLAND MINES LTD dividends, cash for the quarter ending 2022-12-31 was -$73.18K.
- GREENLAND MINES LTD dividends, cash for fiscal 2021 was $4.95K.
| Period end | Dividends, Cash 3 month | Dividends, Cash 6 month | Dividends, Cash 9 month | Dividends, Cash 12 month |
|---|---|---|---|---|
| 2023-09-30 | $22.61K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-17 | $28.35K derived: sum of 2 quarters · filed 2023-11-17 | $146.33K 10-Q · filed 2023-11-17 | $73.15K derived: sum of 4 quarters · filed 2023-11-17 |
| 2023-06-30 | $5.74K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-21 | $123.72K 10-Q · filed 2023-08-21 | $50.54K derived: sum of 3 quarters · filed 2023-11-17 | $17.30K derived: sum of 4 quarters · filed 2023-11-17 |
| 2023-03-31 | $117.98K 10-Q · filed 2023-05-24 | $44.80K derived: sum of 2 quarters · filed 2023-11-17 | $11.56K derived: sum of 3 quarters · filed 2023-11-17 | |
| 2022-12-31 | -$73.18K derived: 10-Q 12 month − 10-Q 9 month · filed 2023-11-17 | -$106.42K derived: sum of 2 quarters · filed 2023-11-17 | $340.96K 10-Q · filed 2023-11-17 | |
| 2022-09-30 | -$33.24K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $414.14K 10-Q · filed 2022-11-14 | ||
| 2022-06-30 | $447.38K 10-Q · filed 2022-08-15 | |||
| 2021-12-31 | $4.95K 10-K/A · filed 2023-10-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | United States | $2.175B | -6.63 |
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 |